Skip to main content
Oria Health
growth hormoneGHRHanti-aging

Sermorelin

GHRH(1–29) analog · pituitary GH secretagogue

A synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH), FDA approved for diagnosing and treating pediatric growth hormone deficiency. Preserves the body's natural pulsatile GH release pattern for optimized GH levels with fewer side effects than direct HGH injection.

Sermorelin
Evidence Grade
A-
Trial Stage
Approved (pediatric)

A synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH), FDA approved for diagnosing and treating pediatric growth hormone deficiency. Preserves the body's natural pulsatile GH release pattern for optimized GH levels with fewer side effects than direct HGH injection.

A-
Evidence Grade
FDA Status
Discontinued
Geref (approved 1997)
Amino Acids
29
first 29 aa of GHRH
GH Increase
Significant
in GHD children & adults
Discontinued
2008
commercial reasons, not safety
Side Effect Profile
Low
Moderate
Serious
Injection site reactions15%
Flushing10%
Headache8%
Dizziness5%
Joint pain3%
Nausea3%
Research Timeline
1980s
GHRH analogue developed
1990
Phase III trials completed
1997
FDA approves Geref
2008
Manufacturer discontinues
2020s
Compounding pharmacy use
Research In Progress·Full clinical analysis pending. Community notes and FAQ available below.

Sermorelin is a 29-amino-acid peptide identical to the active fragment of the growth hormone-releasing hormone (GHRH) your hypothalamus already produces. The full GHRH molecule is 44 amino acids, but research established that the first 29 carry all the biological activity. The FDA approved sermorelin (brand name Geref) in 1997 for diagnosing and treating growth hormone deficiency in children. Off-label adult use for GH optimization became widespread in the 2000s as a safer alternative to direct HGH injection, and the peptide became one of the most widely prescribed compounds in anti-aging medicine following patent expiration.

Sermorelin binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering GH release in a pulsatile pattern that mirrors the body's natural rhythm — primarily during deep sleep and after exercise. This is the key distinction from direct HGH injection. Exogenous HGH bypasses the body's regulatory feedback loops entirely, producing constant elevated GH levels with risk of insulin resistance, joint pain, and fluid retention. Sermorelin works through the pituitary's existing regulatory architecture. After GH release, natural feedback mechanisms (somatostatin, IGF-1) modulate further secretion. The downstream effects include increased IGF-1 production, improved protein synthesis, enhanced lipolysis, better sleep architecture, and improved tissue repair.

Sleep improvement is consistently the first benefit users notice, often within the first week. Body composition changes — reduced fat, preserved lean muscle — are slower but sustained over 3 to 6 months. Exercise recovery improves as GH-driven tissue repair accelerates. The overall effect profile is the same as optimized GH levels, arrived at through a mechanism the body is already designed to use.

Community Experiences

"The first time in years I slept through the night without waking up at 3 AM. Sleep quality improved within the first week. That alone is worth it." — r/Peptides

"The body composition changes are slow — you're not going to look different in a month. But at 12 weeks the difference in how you feel and how you look is real." — r/Peptides

"Compared to injecting actual HGH, sermorelin is just smoother. You're not overriding your body, you're asking it nicely. The side effect profile is completely different." — r/Biohackers

Sermorelin research

Growth hormone secretagogue research for optimized GH release

Frequently Asked Questions

Is sermorelin FDA approved? Yes. Sermorelin was FDA approved in 1997 for diagnosing and treating growth hormone deficiency in children. Adult use for GH optimization is off-label and widely practiced in anti-aging medicine.

How does sermorelin differ from HGH? Sermorelin stimulates the pituitary to release GH in natural pulses. Direct HGH injection bypasses regulatory feedback, providing constant elevated levels with a higher risk of side effects including insulin resistance and joint pain.

What is the typical research dose? Common protocols use 100 to 300 mcg administered subcutaneously at bedtime, aligned with the body's natural GH release pattern during deep sleep.

How long before results appear? Sleep improvements often appear within the first week. Body composition and recovery benefits typically take 8 to 12 weeks of consistent use.

Stacking Suggestions

  • Ipamorelin for a synergistic GH release stack — sermorelin via GHRH receptors, ipamorelin via ghrelin receptors, combined GH output
  • CJC-1295 for extended GHRH receptor stimulation with a longer half-life
  • BPC-157 for tissue repair support while sermorelin optimizes GH levels
  • GHK-Cu for skin health benefits that complement sermorelin's GH-mediated skin improvements
  • MOTS-c for metabolic support alongside GH optimization

Get Your BioStack →